Morningstar

Glorywin Entertainment Group Inc GWIN

Stock OTCM

$0.66 +0.15 (28.71%)

View Full Chart

As of Sep 1, 2026, 7:22:30 PM Delayed Price Closed

Trading Information

Previous Close Price: $0.51
Day Range: $0.66–0.66
52-Week Range: $0.15–3.91
Bid/Ask: $0.39 / $6.00
Shares Outstanding: 356.19M
Market Cap: $234.77M
Volume/Avg: 234 / 362

Key Statistics

Price/Earnings (Normalized): —
Price/Sales: —
Dividend Yield (Trailing): 0.00%
Dividend Yield (Forward): 0.00%
Dividend Payment Schedule: —
Total Yield: —

Company Profile

Glorywin Entertainment Group Inc is a 3D bioprinting technology research and development, and anti-cancer drug research and development.

Sector: Healthcare
Industry: Biotechnology
Stock Style Box: —
Total Number of Employees: 1
Website: https://www.glorywinentertainment.com

Valuation

Metric	GWIN
Price/Earnings (Normalized)	—
Price/Book Value	—
Price/Sales	—
Price/Cash Flow	—

Price/Earnings

GWIN

Financial Strength

Metric	GWIN
Quick Ratio	0.00
Current Ratio	0.00
Interest Coverage	—

Quick Ratio

GWIN

Profitability

Metric	GWIN
Return on Assets (Normalized)	—
Return on Equity (Normalized)	—
Return on Invested Capital (Normalized)	—

Return on Assets

GWIN

Biotechnology Industry Comparables

Screen With Investor

1-Day Chart	Name	Price	Morningstar Rating for Stocks	Capital Allocation	Economic Moat	Market Cap
	Vertex Pharmaceuticals Inc VRTX			LOCK\|Xm^<>@X	LOCK\|PFrrX	$128B
	Moderna Inc MRNA			LOCK\|Yh^G&^H	LOCK\|v#W	$78B
	Regeneron Pharmaceuticals Inc REGN			LOCK\|LW&^y^	LOCK\|cTyF!	$76B
	argenx SE ADR ARGX			LOCK\|<CqtMj	LOCK\|rbR	$59B
	BeOne Medicines Ltd ADR ONC			LOCK\|r%k%@q@	LOCK\|Dyt	$42B
	Alnylam Pharmaceuticals Inc ALNY			LOCK\|bvtl$wk	LOCK\|cLz#	$30B
	Royalty Pharma PLC Class A RPRX			LOCK\|x#&CQc?	LOCK\|W^n#	$25B
	BioNTech SE ADR BNTX			LOCK\|^&Q@M$	LOCK\|^&q	$24B
	Incyte Corp INCY			LOCK\|>&&^?<d	LOCK\|fK<	$23B
	Jazz Pharmaceuticals PLC JAZZ			LOCK\|w#<%@Xm	LOCK\|!lK	$15B

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.